T H E R A P E U T I C N O T E S THE TREATMENT OF URINARY INFECTIONS
I N F I c T I o N s of the urinary tract are next in frequency to respiratory tract ~nfections in the general population, yet far less is known about the mode of infection and the pathogenesis. It is uncertain how many patients, who suffer from acute urinary tract infection, subsequently develop chronic pyelonephritis, but the latter is one of the most common renal lesions found at postmortem examination where death has been due to uraemia and hypertension. Acute and chronic pyelonephritis are several times more common in patients suffering from diabetes mellitus than in the general population, and acute pyelonephritis is one of the most common complications of pregnancy. As in the case of chronic bronchitis, infection, once it becomes established in the kidney, is virtually irremediable and the patient suffers from repeated exacerbations, each one destroying more of the highly specialized renal parenchyma. The intractability and chronicity of many renal infections is one of the outstanding clinical bacteriological problems of the present day.
From a therapeutic point of view, it is unnecessary to distinguish between acute cystitis and acute pyelonephritis. Such a distinction has probably little justification on pathological grounds in any case, and the clinical features of dysuria and frequency are more common manifestations of pyelonephritis than are pain in the renal angles, rigors and chills.
Consideration of the treatment of these infections is commonly prefaced by recommendations to seek and rectify anatomical abnormalities in and around the urinary tract and by the plea that constipation should be avoided. Although there is no doubt that obstruction and paralytic lesions play a part in the genesis and persistence of infection in some patients, the majority have no demonstrable anatomical abnormality and there is no evidence that constipation contributes at all to its development. Renal stones are found in only a small proportion of patients with chronic pyelonephritis and are i~sually secon-dary. There is increasing evidence, however, to incriminate the catheter as the vehicle of infection and there is little doubt that its casual use in pregnancy is responsible for many cases of urinary infection in this condition. Its routine use in pregnancy is to be deprecated and when catheterization is indicated, it should be performed under the most stringent aseptic conditions.
In all but the mildest of attacks the patient with acute pyelonephritis should be confined to bed, and, wherever possible, a specimen of urine (preferably the morning specimen) should be sent to the bacteriological laboratory.
Specific therapy
The use of such measures as acidification of the urine by ammonium chloride, ketogenic diets and the prescription of mandelic acid and sodium mandelate have now been almost completely abandoned in favour of modern chemotherapy. Nevertheless, in their day these measures produced a high rate of success in acute infections due to Esch. coli, and they were free from significant toxicity and from the plague of most modern antibiotics-the development of bacterial resistance. The efficacy of mandelic acid depends entirely upon the establishment of a urinary pH below 5.5, and this fact suggests that present-day preoccupation with effective concentrations of the newer antibiotics in the renal tissues in contradistinction to that in the urine may not be entirely justified.
The sulphonamide group. Sulphadimidine (2.0 g. then 1 g. 6-hourly for 7 days) is the drug of choice in acute urinary infections due to Esch. coli and Aerohacter aerogenes. In recent years, mixtures of sulphonamides possessing the theoretical advantages of increased solubility have been introduced, but it is doubtful whether in all circumstances they are as effective as one of the components alone. Sulphamerazine is commonly included in such a mixture, and this sulphonamide is among the least soluble in urine. Furthermore, the claim that different sulphonamides are synergistic in their effects is extremely doubtful. Provided the patient is urged to drink 4 to 5 pints fluid per day the possibility of crystallization in the renal tubules or ureters with sulphadimidine is virtually nonexistent. Since over 80 per cent of acute urinary bacterial infections are due to Esch. coli, it would seem reasonable to use sulphadimidine in the first instance in all such patients before the results of bacteriological examination are available. Sulphadimidine may sometimes be effective in infections with the other common urinary bacteria, including Proteus vulgaris, Pseudomonas pyocyaneus, Streptococcus faecalis and Staphylococcus aureus. More often than not, however, and particularly in recurrent attacks, organisms are present in various combinations and the best results are obtained by employing information based upon in vitro tests of sensitivity. This, in turn, usually involves the use of the more modern antibiotics, either alone or in combination.
Penicillin. Penicillin (500,000 units intramuscularly 8-hourly) is of little or no value in the treatment of infections due to gramnegative bacilli, such as the coliform group of organisms and the majority of strains of Proteus vulgaris. Staphylococcal infection in hospital patients, or in those whose urinary tract infection has been introduced by catheterization, is due, in the great majority of cases, to organisms which are penicillinresistant. This is not so in patients with no recent period of stay in hospital or history of recent administration of penicillin, and in these circumstances penicillin may prove to be of value. Opinion is unanimous that penicillin is of greatest usefulness in urinary infections due to Streptococcus faecalis, but infection with this organism is uncommon in this country. With these reservations, therefore, penicillin is of limited value in the treatment of urinary infections.
Streptomycin sulphate. Streptomycin (I g. daily for 5 days) suffers from several disadvantages with regard to the treatment of urinary infections. Of all the commonly employed antibiotics, it is the most likely to induce bacterial resistance rapidly. In addition, unless specific steps have been taken to exclude tuberculosis, there is a real danger of inducing streptomycin resistance in this organism. This is particularly liable to occur when the antibiotic is given alone and if repeated courses are administered. There is the added practical disadvantage that it requires to be given by injection. The only indication for its use is the presence of organisms resistant to all other antibiotics, and under these conditions short courses of not more than 5 days should be given. The lack of success which has been reported with streptomycin in these circumstances is undoubtedly due, in part, to failure to keep the urine alkaline with sodium bicarbonate when this drug is being given. The activity of streptomycin increases tenfold for every unit rise in pH.
Chloramphenicol. Chloramphenicol (2 g. daily for 5 days) is a wide spectrum antibiotic conveniently given by the oral route. The drug is most useful in the treatment of infections due to sulphonamide-resistant Esch. coli, some strains of Proteus vulgaris, Streptococcus faecalis and penicillin-resistant staphylococci. It is useless in infections with Pseudomonas pyocyaneus. Chloramphenicol is a valuable antibioticin the treatment of urinary infections and there seems little doubt that the danger of toxic depression of the haematopoietic system has been exaggerated.
Tetracyclines. The major difficulty in the use of the tetracyclines (2 g. daily for 5 days) has been the occurrence of gastrointestinal side effects, which range from mild diarrhoea to severe and even fatal infection with monilia and resistant staphylococci. For these reasons it is wisest to reserve tetracyclines for the treatment of infections due to organisms of proved sensitivity which are resistant to sulphadimidine, penicillin and chloraniphenicol.
Nitrofurantoin (Furodantin) . Nitrofurantoin (100 mg. 4 times a day for 7-14 days) is a new urinary antiseptic unrelated chemically either to the sulphonamides or to the antibiotics. When given by mouth, it is effective against both gram-positive and gram-negative organisms commonly found in the urinary tract. This drug is indicated in mixed infections, and especially those which have proved resistant to other drugs. It is particularly valuable in resistant proteus infections. Bacterial resistance to this drug is rare, both in vitro and in vivo. Side effects are uncommon, though nausea, vomiting and skin rashes have been reported. Nitrofurantoin is contraindicated Therapeutic Notes in oliguria, anuria and in the presence of severe renal damage.
In the great majority of first attacks of pyelonephritis, treatment with sulphonamide is successful in eradicating the infection, but its success should be tested by the bacteriological examination of a specimen of urine after treatment has been stopped. This should be delayed, however, for some weeks after the end of the course of treatment, in order to make sure that the infection has been eliminated rather than merely suppressed. I n the case of infections with mixed organisms and in chronic pyelonephritis, treatment is less satisfactory and should be guided by adequate bacteriological studies. Combinations of multiple antibiotics may be indicated and used, but results so far have been disappointing as resistance to all drugs in the combination may emerge. In these circumstances a return to the older remedies may be of some value and sodium mandelate, with acidification of the urine, may be all that can be offered. It is in these patients particularly that investigation of the urinary tract by intravenous or retrograde pyelography may be indicated.
Other aspects of the treatment of chronic pyelonephritis
The occurrence of chronic pyelonephritis commonly leads to the development of certain features which are not directly due to the infection per se, but are a consequence of the disturbed renal function. These include hypertension, anaemia, and sodium, water and potassium depletion. For many years symptoms arising from these disorders may dominate the clinical picture and cause distress greater than that produced by the infection itself. Appropriate treatment should be given in each case. Hypotensive drugs are disappointing, however, in the presence of moderately advanced renal failure. Anaemia responds only to transfusion of blood, and it may be necessary in other patients to supplement the diet with 5 to 10 g. of sodium chloride daily, asking the patient to continue to drink up to 5 to 6 pints of fluids per day.
